Clinical Trial Update: Use of a Novel Contact Force Sensing Catheter for AF Ablation - Impact of TactiCath on Dormant Conduction Across the Pulmonary Veins

View source ↗

Summary

A clinical trial evaluating a novel contact force sensing catheter (TactiCath) for atrial fibrillation ablation has been withdrawn, with no reported results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Dhanunjaya Lakkireddy, MD, FACC | Conditions: Atrial Fibrillation | Status: WITHDRAWN